As Covid cases decline, our job in the ER feels just like it used to for the first time since the virus surged into our hospitals.
It was a year ago that we made this animated video to show what a “normal” day on the Covid front lines looked like...
Even if our job is getting back to normal, to be honest, it was never a cakewalk. We see really sick patients every shift, and sadly some of our patients die.
But Covid brought a whole new level of chaos and craziness.
We're back to doing the stuff we know so well. Sprains, chest pain, pulling bugs outta peoples ears.
And we're starting to see our patients come back. ER visits dropped A LOT during the pandemic. We were all worried patients were delaying emergency care.
We prioritized high-risk groups for vaccination. You know, like the elderly. As in, some of the same people whose risk of dying was actually just kinda high at baseline.
Did some of them die after getting a vaccine? Yes.
It’s great the Pfizer vaccine appears to be safe and effective for 12-15 year olds!
But we need to ask if that’s really the group to prioritize for vaccination right now. We’re holding doses for them while healthcare workers around the world remain unprotected.
Yes, vaccinating US 12-15 year olds will help open schools safely in the fall.
But healthcare workers in India, Latin America & all over the world are dying NOW from Covid-19.
A crush of patients, insufficient PPE and extremely limited access to vaccine leaves them vulnerable.
Instead of launching a campaign to get 12-15 year olds vaccinated in the US, the US donate those doses internationally, focused on getting healthcare workers in global hotspots vaccinated.
We can and must do more to get them vaccinated and protected from Covid.
The pandemic is splitting in two. While the 🇺🇸 vaccinates its way out of the nightmare, Covid is raging around the 🌍. Yet just 0.2% of all Covid vaccines are going to low-income countries.
1. The U.S. has secured deals for over 1.2 billion doses of Covid-19 vaccines from six companies. That’s more than enough to vaccinate every American several times over.
As vaccine demand starts to lag in the U.S. and doses pile up, we need a plan for how we’ll share the excess.
The most obvious solution is donating the vaccine to the @WHO initiative COVAX to deliver Covid vaccines equitably to countries around the world.
Sharing our bounty would immediately help address Covax’s supply shortage. It would also reestablish the US as a global health leader
Last week was the worst of the pandemic to date, with over 5.2 million new cases globally.
Yet the U.S. is sitting on millions of doses of Astra Zeneca vaccine that we haven’t approved for use (and almost certainly won’t need) while the rest of the world scrambles for supply.
Over a month ago, I (and many others) called for the U.S. to donate these doses immediately. Yet still they sit on a shelf while the pandemic picks up steam.
Meanwhile, new #COVID19 numbers have increased globally for 8 consecutive weeks.
The many hot takes on here that the complications from J&J are so rare we shouldn’t have paused it’s use are persuasive at face value. The pandemic IS still raging. We NEED shots in arms. And the risk is SO low! This is all true.
But that argument is missing something critical.
If my loved one was among the 6 with a complication AND the FDA/CDC/US govt knew there was a signal but didn’t act, I’d be furious.
I really appreciate the transparency here.
They could’ve easily argued this away...”this is the background rate of clots” etc. But they didn’t.
Will this mean it’ll be harder to convince many, especially younger women, to get the J&J vaccine if/when we start using it widely again? Yes.
...even if the risk is shown to be much lower than Covid, getting struck by lighting, or dying from a vending machine crushing you? Yes.
Right now wealthy countries like the US are sitting on millions of doses of this vaccine.
It’s not even authorized for use in the US, and won’t be for weeks.l at best.
A few days ago the US announced it would loan millions of doses to Canada & Mexico... npr.org/2021/03/19/979…
But we’re still sitting on millions of doses. And have ordered 300 million doses. Yes.
When the president pledged there would be enough vaccine for everyone eligible by the end of May, the AstraZeneca vaccine wasn’t even considered in the calculation.